Asulacrine DNA intercalating agent and inhibitor of topoisomerase II: SPTA began a second Phase I trial

Sparta Pharmaceuticals Inc. (SPTA), Horsham, Penn. Product: Asulacrine DNA intercalating agent and inhibitor of topoisomerase II Indication: Breast and lung cancers Status: SPTA began a second Phase ...